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Abstract We have investigated the levels of several antioxidant 
enzymes and the level of oxidative DNA base damage in 
lymphocytes of children with acute lymphoblastic leukemia 
(ALL) and in disease-free children. Children with ALL had just 
been diagnosed with the disease and had received no therapy 
prior to obtaining blood samples. A multitude of typical hydroxyl 
radical-induced base lesions in lymphocyte DNA of children were 
identified and quantified by gas chromatography-isotope dilution 
mass spectrometry. Higher levels of DNA base lesions were 
observed in patients with ALL than in children without the 
disease. The levels of the antioxidant enzymes glutathione 
peroxidase, catalase and Superoxide dismutase in lymphocytes 
of ALL patients were lower than in lymphocytes of controls. 
These findings are in agreement with earlier observations in 
various types of adulthood cancer. Some of the identified DNA 
base lesions are known to possess premutagenic properties and 
may play a role in carcinogenesis. The results may indicate a 
possible link between decreased activities of antioxidant enzymes 
and increased levels of DNA base lesions due to oxidative 
damage, and support the notion that free radical reactions may 
be increased in malignant cells. 
© 1997 Federation of European Biochemical Societies. 
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1. Introduction 
Oxygen-derived free radicals are formed in aerobic organ-
isms by normal cellular metabolism or by endogenous sources 
(reviewed in [1]). These species can cause damage to biomol-
ecules including DNA, and thus be mutagenic and carcino-
genic. Of free radicals, the hydroxyl radical (ΌΗ) is highly 
reactive and generates a multitude of modifications in DNA 
(reviewed in [2,3]). This type of damage, also called oxidative 
DNA damage, is implicated in mutagenesis, carcinogenesis 
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and aging [1]. Antioxidant enzymes such as Superoxide dis-
mutase (SOD), catalase (CAT) and glutathione peroxidase 
(GPx) protect cells from the toxic effects of oxygen-derived 
species [1]. Of these species, Superoxide radical (OjT) and 
H 2 0 2 do not cause any DNA damage under physiological 
conditions [4-6]. The toxicity of O^ and H2O2 results from 
their metal-ion catalyzed reactions leading to "OH [1]. 
There is evidence that cancer cells produce larger amounts 
of oxygen-derived species than non-neoplastic cells and that 
the antioxidant system of cancer cells is suppressed [7]. Several 
carcinoma cell lines have been found to produce large 
amounts of H2O2 [8]. Low antioxidant enzyme activities are 
a common characteristic of cancer cells (reviewed in [9,10]). 
These facts indicate that there is a persistent oxidative stress in 
cancer [7] and cancer cells are more exposed to oxygen-de-
rived species than their normal counterparts. Recent findings 
clearly showed elevated levels of typical ΌΗ-modified DNA 
bases in various cancerous tissues than in their surrounding 
normal tissues [11-15]. Furthermore, there is evidence of an 
association between increased levels of modified DNA bases 
and decreased levels of antioxidant enzymes in human cancer-
ous tissues [13]. Although not cancerous, human benign pro-
static hyperplasia tissues have been shown to have higher 
oxidative DNA damage and lower antioxidant enzyme activ-
ities than surrounding normal prostate tissues [16]. 
Levels of oxidative DNA damage and antioxidant enzymes 
have not been investigated in any childhood cancer. In this 
work, we studied the endogenous levels of typical 'OH-modi-
fied DNA bases and activities of SOD, CAT and GPx in 
blood lymphocytes of children with acute lymphoblastic leu-
kemia (ALL). ALL is a malignant, clonai disorder of bone 
marrow lymphopoietic precursor cells and the onset of the 
disease is acute or subacute in previously healthy children, 
but rare in adults [17]. Nine children with ALL and 10 dis-
ease-free children between the ages of 3 and 12 were involved 
in this study. We wished to see whether this type of childhood 
cancer possesses characteristics similar to other types of can-
cers previously investigated, in terms of levels of oxidative 
DNA damage and antioxidant enzymes. 
2. Materials and methods 
2.1. Materials 
Certain commercial equipment or materials are identified in this 
paper in order to specify adequately the experimental procedure. 
Such identification does not imply recommendation or endorsement 
by the National Institute of Standards and Technology, nor does it 
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Table 1 
Activities (U/mg of proteina) of antioxidant enzymes in lymphocytes 
of children with ALL and in lymphocytes of disease-free children 
Enzyme Control ALL 
CAT 
GPx 
SOD 
5.0611.96 
137.2 ±32.4 
86.1126.0 
2.36±0.63b 
76.2±20.6b 
41.1 ± 10.4b 
aValues represent the mean ± standard deviation (n = 10 for controls, 
n = 9 for ALL patients). 
''Significantly different from control (P<0.05 by Student's i-test). 
imply that the materials or equipment identified are necessarily the 
best available for the purpose. 
Modified DNA bases, their stable isotope-labeled analogues and 
other materials for gas chromatography/mass spectrometry were ob-
tained as described [18]. Labeled 2'-deoxyguanosine (2'-deoxyguano-
sine-15N5) was purchased from Cambridge Isotope Laboratories 
(Andover, MA, USA). 
2.2. Blood samples, measurement of enzyme activities and isolation 
of DNA 
Venous blood samples (15 ml) were drawn from nine children with 
ALL and 10 disease-free children between the ages of 3 and 12 at the 
Department of Pediatrics, Faculty of Medicine, University of Istan-
bul, Turkey. In all cases, the consent of the families for obtaining 
blood samples was received. Children with ALL had just been diag-
nosed with the disease and had not received any therapy prior to 
obtaining blood samples. 10 ml of blood was collected from each 
subject in tubes containing heparin and lymphocytes were isolated 
[19]. Lymphocytes were sonicated for 20 s and then centrifuged at 
15000Xg for 20 min. The supernatant fractions were used to deter-
mine the activities of CAT, and GPx and the total activity of SOD 
(Cu,Zn-SOD and Mn-SOD) according to established methods [20-22]. 
Briefly, the activity of CAT was determined by measurement of H 2 0 2 
concentration using UV absorbance at 240 nm. The conversion of 
NADPH to NADP was utilized using measurement of UV absorb-
ance at 340 nm for determination of the activity of GPx. The activity 
of the total SOD was determined using the inhibition by SOD of the 
reaction of Oj" with nitroblue tetrazolium. Protein content was deter-
mined using a Lowry protein kit. For DNA isolation, 5 ml of blood 
was collected in EDTA-coated tubes. Lymphocytes were separated as 
described above. Subsequently, DNA was isolated from lymphocytes 
[23]. 
2.3. Analysis by gas chromatography/mass spectrometry 
The concentration of DNA was estimated by the measurement of 
absorbance at 260 nm (absorbance of 1 = 50 μg of DNA/ml). Aliquots 
of stable isotope-labeled analogues of modified DNA bases were 
added as internal standards to 50 μg of DNA. An aliquot of 2'-
deoxyguanosine-15N5 was also added for quantification of guanine 
to assess by mass spectrometry the DNA amount in each sample. 
Upon hydrolysis, 2'-deoxyguanosine-15N5 yields guanine-
15N5, which 
is used as an internal standard for guanine in DNA [24]. Samples were 
dried under vacuum in a SpeedVac and then hydrolyzed with 0.5 ml 
of 60% formic acid in evacuated and sealed tubes at 140°C for 30 min. 
The hydrolyzates were lyophilized in vials for 18 h. Lyophilized hy-
drolyzates were derivatized and then analyzed by gas chromatogra-
phy/isotope-dilution mass spectrometry with selected-ion monitoring 
as described [25]. 
3. Results 
We investigated endogenous levels of antioxidant enzymes 
and oxidative D N A base damage in lymphocytes of children 
with A L L and disease-free children. Children with A L L were 
just diagnosed with the disease and had undergone no chemo-
therapy prior to this study. The objective of this study was to 
see whether this childhood cancer possesses characteristics 
similar to adult cancers previously investigated concerning 
antioxidant enzymes and potentially mutagenic D N A lesions. 
The activities of SOD, C A T and GPx in lymphocytes of 
children with A L L and disease-free children are given in Table 
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Fig. 1. Levels of activities of CAT, GPx and SOD in lymphocytes of individual ALL patients and disease-free children. Each data point corre-
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tients. 
288 S. Sentürker et allFEBS Letters 416 (1997) 286-290 
<r 
7 
n 
о 
hf) 
e _^ ί 
и 
с 
с 
3 
о 
fi cd 
0.4 
0.35 
0.3 
0.25 
0.2 
0.15 
0.1 
0.05 
0 
5-OH-Cyt 
D α 
D 
■ ■ 
— ι 1 1 1 г 
0 2 4 6 8 10 
patient number patient number 
< 
Z 
Q 
о 
so 
.6 
"о 
e 
patient number 
< 
Z 
Q 
см 
О 
ьо 
fi 
0 . 5 -
0 . 4 -
0 . 3 -
0 . 2 -
0.1 -
€ 
8-OH-Ade 
П 
■ 
D 
■ 
1 
2 
g 
D 
■ 
1 
4 
D 
■ 
П 
■ 
1 
6 
□ 
■ 
D 
■ 
1 
8 
a 
■ 
■ 
1 
10 
patient number 
Fig. 2. Levels of four modified DNA bases in lymphocytes of individual ALL patients and disease-free children. Each data point corresponds 
to one individual. The same individual has the same number in each plot and the numbers were given arbitrarily. ■. controls; D, patients. 
1 nmol/mg of DNA corresponds to approximately 32 lesions/105 DNA bases. 
1. The levels of all three enzymes in ALL patients were found 
to be significantly decreased compared to the levels in disease-
free children. Fig. 1 illustrates the enzyme levels in lympho-
cytes of individual patients and controls. These plots clearly 
show the differences between patients and controls and, as 
expected, the individual variations among patients and among 
normal children. It should be pointed out that the identifica-
tion numbers of individuals were arbitrarily chosen, and each 
individual has the same number on each plot. 
Nine modified DNA bases were identified and quantified in 
lymphocyte DNA samples of children with ALL and disease-
free children. These were 5-hydroxycytosine (5-OH-Cyt), 5-
hydroxyuracil (5-OH-Ura), 5,6-dihydroxyuracil (5,6-diOH-
Ura), 5-hydroxy-5-methylhydantoin (5-OH-5-MeHyd), 5-hy-
Table 2 
Levels of modified DNA bases (nmol/mg of DNAa) in lymphocytes 
of children with ALL and in lymphocytes of disease-free children 
Modified base Control ALL 
FapyGua 
8-OH-Gua 
FapyAde 
8-OH-Ade 
5-OH-Cyt 
5-OH-Ura 
5-OH-5-MeHyd 
5-OH-Hyd 
5,6-diOH-Ura 
0.094 + 0.032 
0.269 + 0.077 
0.043 + 0.014 
0.14210.039 
0.097 ±0.024 
0.053 + 0.030 
0.089 + 0.043 
0.08410.03 
0.01110.006 
0.292 ±0.035b 
0.621 ±0.278b 
0.085 ±0.012b 
0.304 ±0.105b 
0.245 ±0.073b 
0.06410.033 
0.286 ±0.065b 
0.269 ±0.057b 
0.013 + 0.003 
"Values represent the mean 1 standard deviation (n = 10 for controls, 
n = 9 for ALL patients). 1 nmol/mg of DNA corresponds to approx-
imately 32 lesions/105 DNA bases. 
bSignificantly different from control (P<0.05 by Student's i-test). 
droxyhydantoin (5-OH-Hyd), 2,6-diamino-4-hydroxy-5-for-
mamidopyrimidine (FapyGua), 8-hydroxyguanine (8-OH-
Gua), 4,6-diamino-5-formamidopyrimidine (FapyAde) and 
8-hydroxyadenine (8-OH-Ade). The structures of these modi-
fied bases can be found elsewhere [18]. The levels of nine 
modified DNA bases are given in Table 2. The mean values 
of the levels of seven of the modified bases in DNA samples 
from ALL patients were significantly higher than those from 
disease-free children. In the case of FapyGua, 5-OH-5-MeHyd 
and 5-OH-Hyd, the increases were more than 3-fold (Table 2). 
No significant differences for the mean values of 5-OH-Ura 
and 5,6-diOH-Ura between the patients and controls were 
observed. As examples, Fig. 2 illustrates the levels of four 
modified DNA bases in lymphocytes of individual patients 
and controls. These plots clearly demonstrate the differences 
between the patients and disease-free children. Substantial in-
dividual variations among the patients were noted whereas the 
levels of modified bases in controls were somewhat similar to 
one another. 
4. Discussion 
The results of the present work show lower activities of 
three antioxidant enzymes in lymphocytes and higher endog-
enous levels of typical ΌΗ-induced products of DNA bases in 
lymphocyte DNA of children with ALL when compared to 
children without the disease. The findings suggest a possible 
link between increased levels of oxidative DNA damage and 
decreased levels of antioxidant enzymes in ALL. 
The levels of GPx, CAT and SOD were consistently lower 
in ALL patients than in control children. A statistically sig-
nificant 2-fold difference between the patient group and the 
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control group was observed for all three enzymes. There were 
also differences of up to 2-3-fold between individuals in each 
group, reflecting possible individual variations in enzyme ac-
tivities. Nine modified DNA bases were quantified in DNA of 
lymphocytes. The levels of seven of these lesions in ALL pa-
tients were significantly higher than those found in controls. 
The results of this work are consistent with earlier obser-
vations of higher levels of typical ΌΗ-induced DNA lesions 
in various human cancerous tissues than in their cancer-free 
surrounding tissues [11-14]. The difference between those 
studies and the present study is that tissues from the same 
individual, i.e. cancerous tissue versus cancer-free surrounding 
tissue, were compared in earlier studies, whereas, in this work, 
lymphocyte DNA samples were compared between cancer 
patients and disease-free children. The findings on antioxidant 
enzymes in this work are also in agreement with an earlier 
report that antioxidant enzyme activities in human lung can-
cerous tissues were higher that those in their surrounding 
cancer-free tissues [13]. Recently, similar findings were re-
ported on DNA base damage and activities of antioxidant 
enzymes in human benign prostatic hyperplasia tissues and 
surrounding disease-free tissues [16]. 
In general, activities of antioxidant enzymes in tumor cells 
have been found to be lower than in normal cells [10]. In fact, 
in tumor cells, Mn-SOD activity is always low, CAT activity 
is almost always low and Cu,Zn-SOD activity is usually low. 
On the other hand, levels of GPx were found to be highly 
variable in some tumor cell lines and higher in others [10]. 
The results of this work are consistent with the general trends 
observed in previous studies. Decreased levels of GPx, SOD 
and CAT may cause the accumulation of O j and H 2 0 2 in 
tumor cells [10]. Moreover, human cancer cells have been 
shown to produce excess amounts of H 2 0 2 [8]. Since H 2 0 2 
itself is not reactive, it may pass through cellular membranes 
and reach any cellular compartment including the nucleus and 
DNA [1]. This may result in greater DNA damage in tumor 
cells than in normal cells by production of Ό Η from reactions 
of H 2 0 2 with DNA-bound metal ions [1]. In fact, the treat-
ment of human and other mammalian cells with H 2 0 2 or with 
activated leukocytes has been shown to induce modification of 
all four bases in cellular DNA with a pattern similar to that 
observed in the present work [26-28]. Higher levels of oxida-
tive DNA base damage as observed in ALL patients and ear-
lier in other cancers support the hypothesis that free radical 
reactions may be increased in malignant cells concurrent with 
decreased levels of antioxidant enzymes [7,9]. 
It is not known whether an increase in the endogenous level 
of oxidative DNA damage concurrent with a decrease in the 
levels of antioxidant enzymes plays a causative role in carcino-
genesis, or is merely a result of the disease. Some of the DNA 
lesions that were found in ALL patients in increased amounts 
have been shown to possess premutagenic properties. 8-OH-
Gua, which is the most investigated lesion, has been found to 
cause GC->TA transversions [29-32]. The other prominent 
purine lesion, 8-OH-Ade, possesses premutagenic properties 
in mammalian cells [33]. 5-OH-Cyt appears to be more muta-
genic than any other DNA lesion thus far investigated [34,35]. 
On the other hand, the mutagenic effects of the remaining 
DNA base lesions, which were found in ALL patients in in-
creased levels, are not known [36]. These lesions may also 
contribute to the mutagenic effects of oxidative DNA base 
damage. The findings on the mutagenic effects of oxidative 
DNA lesions may indicate an important role for the lesions 
in carcinogenesis. Increased levels of oxidative DNA lesions 
may also contribute to the genetic instability and metastatic 
potential of cancerous cells in ALL and other cancers [15]. 
In conclusion, the present work provides evidence for in-
creased levels of oxidative DNA base damage and decreased 
levels of antioxidant enzymes in lymphocytes of ALL patients, 
suggesting a possible link between these two important pa-
rameters in this cancer. The results of this work are consistent 
with previous observations on other human cancerous tissues. 
Higher levels of DNA base lesions may indicate an increase in 
free radical reactions in ALL cells and may contribute to their 
genetic instability and metastatic potential. 
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